
immunology

Long-lived bats appear to combine powerful immune defenses with unusual strategies for eliminating damaged cells, potentially helping them avoid cancer and disease for decades. Researchers hope these genetic tricks could eventually reveal new ways to protect human health during aging.

Researchers tested whether targeting immunosuppressive cells could strengthen focused ultrasound treatment in preclinical models of breast cancer.

Researchers tested whether targeting immunosuppressive cells could strengthen focused ultrasound treatment in preclinical models of breast cancer.
Adelaide University researchers have developed a new way of using mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anti-cancer immune response.
Why do genetic variants that increase the risk of autoimmune disease remain so common in the population?
Nature Communications, Published online: 11 September 2026; doi:10.1038/s41467-026-77812-6 Anti-IgLON5 disease is a rare neuro-immunological disorder characterized by the production of autoantibodies against the cell adhesion molecule, IgLON5. Here, the authors examine the B cell receptor repertoire of an individual with this condition and present a cryo–electron microscopy structure of a patient…
[GentiBio, Inc. (AllSci)] GentiBio, Inc. has received a USD 1.07 million NIH Phase II grant from the National Institute of Diabetes and Digestive and Kidney Diseases to advance an allogeneic, off-the-shelf engineered Treg therapy for newly diagnosed type 1 diabetes. q

By reproducing elements of human bone marrow on a chip, scientists have created a new tool that will help them gain new insights into how immune cells develop and function. The post Bone Marrow-on-a-Chip Model Offers New Window Into Immune Cell Development and Behavior appeared first on GEN - Genetic Engineering and Biotechnology News .

The same technology used to deliver mRNA in COVID-19 vaccines is being used to target a type of immune cell that can help tumours evade the body's defences. Adelaide University researchers have effectively reprogrammed these cells so they can do their job and fight cancer.

The same technology used to deliver mRNA in COVID-19 vaccines is being used to target a type of immune cell that can help tumours evade the body's defences. Adelaide University researchers have effectively reprogrammed these cells so they can do their job and fight cancer.

research.ioSign up to keep scrolling
Create your feed subscriptions, save articles, keep scrolling.






